FORM 603 REVIEW DRAFT — IPD Page 1 FORM 603 — NOTICE OF INITIAL SUBSTANTIAL HOLDER ImpediMed Limited (ASX: IPD) | ACN 089 705 144 1. Details of substantial holder Proposed group: Stephen Edward Mahnken; Dior Leone Mahnken; Stephen Edward Mahnken and Dior Leone Mahnken as trustees for the...
Notice of Initial Substantial Holder
Filed with ASX ·
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call6ix hasn’t read this filing yet.
Earlier from Impedimed
- Change of Director's Interest Notice - Mr Erik Anderson
- Update on Options
- Date of 2026 Annual General Meeting
- Appendix 4G and Corporate Governance Statement
- 2026 Annual Report
Later from Impedimed
- Application for quotation of securities - IPD
- Notice of Annual General Meeting & Voting Form
- Annual General Meeting - Online Meeting Guide
- Change of Director's Interest Notice - Ms Janelle Delaney
- Notification of Q1 FY27 Quarterly Results Investor Webinar
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed